Vector Science and Therapeutics (TSXV:PAIN) FCF Margin %: 0.00% (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:PAIN Vector Science and Therapeutics Corp TSXV:PAIN
14 GF Score
Price C$1.55
View Full Analysis

What is Vector Science and Therapeutics FCF Margin %?

Vector Science and Therapeutics TSXV:PAIN -4.32% 14 FCF Margin % is 0.00% as of Feb. 2026. GuruFocus rates TSXV:PAIN with a GF Score™ of 14/100. Among 815 Medical Devices & Instruments companies, Vector Science and Therapeutics ranks worse than 122699.26% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vector Science and Therapeutics's Free Cash Flow for the three months ended in Feb. 2026 was C$-1.58 Mil. Vector Science and Therapeutics's Revenue for the three months ended in Feb. 2026 was C$0.00 Mil. Therefore, Vector Science and Therapeutics's FCF Margin % for the quarter that ended in Feb. 2026 was 0.00%.

As of today, Vector Science and Therapeutics's current FCF Yield % is -33.82%.

The historical rank and industry rank for Vector Science and Therapeutics's FCF Margin % or its related term are showing as below:


TSXV:PAIN's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.56
* Ranked among companies with meaningful FCF Margin % only.

Vector Science and Therapeutics FCF Margin % Related Terms

Vector Science and Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Vector Science and Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vector Science and Therapeutics FCF Margin % Chart

Vector Science and Therapeutics Annual Data
Trend Aug24 Aug25
FCF Margin %
0.00 0.00

Vector Science and Therapeutics Quarterly Data
Aug24 Nov24 Aug25 Nov25 Feb26
FCF Margin % 0.00 0.00 0.00 0.00 0.00

TSXV:PAIN vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Vector Science and Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vector Science and Therapeutics FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vector Science and Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vector Science and Therapeutics's FCF Margin % falls into.


TSXV:PAIN
14GF Score
Vector Science and Therapeutics Corp TSXV:PAIN
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vector Science and Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vector Science and Therapeutics's FCF Margin for the fiscal year that ended in Aug. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Aug. 2025 )/Revenue (A: Aug. 2025 )
=-1.1/0
= %

Vector Science and Therapeutics's FCF Margin for the quarter that ended in Feb. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-1.576/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Vector Science and Therapeutics (TSXV:PAIN) has a FCF Margin % of 0.00% as of Feb. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vector Science and Therapeutics and its competitors. According to the industry distribution chart, Vector Science and Therapeutics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is Vector Science and Therapeutics' FCF Margin % too high?
Vector Science and Therapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Vector Science and Therapeutics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Vector Science and Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vector Science and Therapeutics' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vector Science and Therapeutics ranks #999999 out of 815 companies for FCF Margin %. This places Vector Science and Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vector Science and Therapeutics and its competitors. Vector Science and Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vector Science and Therapeutics stock overvalued right now?
Vector Science and Therapeutics (TSXV:PAIN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Vector Science and Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vector Science and Therapeutics (TSXV:PAIN), the current FCF Margin % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vector Science and Therapeutics Business Description

Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
14GF Score

Get the complete analysis for TSXV:PAIN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.55
Price